Company / Capital Returned to Shareholders per Share
IRADIMED CORP Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.18
FY2025
5-year range
$1.00 / $1.18
FY2021-FY2025
Trend
+9.5%
vs FY2024
Sector context
#57 of 108
Health Care
What the data says
At $1.18, IRADIMED CORP's capital returned to shareholders per share ranks #57 of 108 in the Health Care sector. Capital Returned to Shareholders per Share has increased for 6 consecutive years, from $0.89 in FY2016 to $1.18 in FY2025.
Based on SEC 10-K filings.
1.18 in FY2025 with a 3-year CAGR of +5.9%.
Improved from $1.05 to $1.18 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +5.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-75.8% below sector average
Key checks
Key Insights
- IRADIMED CORP's capital returned to shareholders per share has grown for 3 consecutive years.
- In FY2025, capital returned to shareholders per share increased 9.5% year-over-year.
- Ranks #57 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.18 | +9.5% |
| FY2024 | $1.08 | +2.9% |
| FY2023 | $1.05 | +5.3% |
| FY2022 | $1.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.94 | +1.2% |
| FY2017 | $0.93 | +4.2% |
| FY2016 | $0.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026